Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ACALABRUTINIB vs ACARBOSE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ACALABRUTINIB vs ACARBOSE: Safety Overview

Metric ACALABRUTINIB ACARBOSE
Total FAERS Reports 9,688 1,770
Deaths Reported 2,239 84
Death Rate 23.1% 4.7%
Hospitalizations 2,441 915
Average Patient Age 73.2 yrs 65.9 yrs
% Female Patients 36.8% 55.0%
FDA Approval Date Aug 3, 2022 Aug 18, 2020
Manufacturer AstraZeneca Pharmaceuticals LP Strides Pharma Science Limited
Route ORAL ORAL
Marketing Status Prescription Discontinued